ARTICLE | Company News
BioRelix, Merck in antibacterial discovery deal
October 4, 2010 11:49 PM UTC
BioRelix Inc. (New Haven, Conn.) partnered with Merck & Co. Inc. (NYSE:MRK) to discover and develop antibacterial drug candidates. BioRelix will screen compounds from Merck's library against proprieta...